Planned phase III trial of RUT58-60.

Trial Profile

Planned phase III trial of RUT58-60.

Phase of Trial: Phase III

Latest Information Update: 14 Apr 2015

At a glance

  • Drugs RUT 58 60 (Primary)
  • Indications Infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Ruthigen
  • Most Recent Events

    • 14 Apr 2015 Planned initiation date changed to 1 Dec 2015.
    • 29 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top